Archives of Timeline Stories - Affluent Medical

2021

Approval from the Spanish and Italian competent authorities for the launch of the Minerva pilot clinical study in the centres of Murcia and Florence.   Management team strengthening with the arrival of Wenzel Hurtak as Vice President Operation for the Epygon...

2020

Affluent Medical’s capital strengthening with private placements worth €10.3 million and €4.1 million respectively.   Kephalios and Epygon receive €2.3 million in grants and repayable advances from THE PSPC Mivana project with the completion of new...

2019

First key stage of the PIAVE Artus project successfully completed with the payment to MyoPowers of grants and advances repayable by Bpifrance for an amount of €3.8 million.   Management team strengthening with the appointment of Michel Finance as CEO, and...

2018

Given their joint undertakings and the synergies that could potentially be generated, grouping of Epygon, Kardiozis, Kephalios and MyoPowers, to create Affluent Medical.   Formation of the Company and operation of contributions in kind of all the shares and...

2017

Entering into joint venture contracts between Shanghai Zuquan Investment Management Company Limited on one side and Epygon, Kephalios and MyoPowers on the other side.